Readline
Shenzhen
About Readline
Readline is a bio-pharmaceutical high-tech company with a multidisciplinary application based on enzyme catalysis technology. It is the world's first company to use directed evolution of enzymes in the large-scale production of API such as peptides, carbohydrate, and nucleic acids on an all-green basis. These APIs are primarily used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers, and other applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $127.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2025)
- Website: szreadline.com
- Phone: +86 0755-2665 9310
Industries & Categories
Agriculture, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/readline-80430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.